Oleoyl Coenzyme A regulates interaction of transcriptional regulator RaaS (Rv1219c) with DNA in Mycobacteria by Turapov, Obolbek et al.
Oleoyl Coenzyme A Regulates Interaction of Transcriptional
Regulator RaaS (Rv1219c) with DNA in Mycobacteria*
Received for publication, April 30, 2014, and in revised form, July 7, 2014 Published, JBC Papers in Press, July 10, 2014, DOI 10.1074/jbc.M114.577338
Obolbek Turapov‡1, Simon J. Waddell§1, Bernard Burke‡, Sarah Glenn‡, Asel A. Sarybaeva‡, Griselda Tudo¶2,
Gilles Labesse?**, Danielle I. Young‡‡, Michael Young‡‡, Peter W. Andrew‡, Philip D. Butcher¶,
Martin Cohen-Gonsaud?**, and Galina V. Mukamolova‡3
From the ‡Department of Infection, Immunity and Inflammation, University of Leicester, Leicester LE1 9HN, United Kingdom, the
§Brighton and Sussex Medical School, University of Sussex, Brighton BN1 9PX, United Kingdom, the ¶Medical Microbiology, Centre
for Infection and Immunity, Division of Clinical Sciences, St. George’s University of London, London SW17 0RE, United Kingdom, the
?Centre de Biochimie Structurale, CNRS UMR 5048, 34090Montpellier, France, **INSERMU1054, Universités Montpellier I and II,
34090Montpellier, France, and the ‡‡Institute of Biological, Environmental and Rural Sciences, Aberystwyth University,
Aberystwyth SY23 3DD, United Kingdom
Background: RaaSmediates mycobacterial survival in nonpermissive growth conditions by controlling expression of ATP-
dependent efflux pumps.
Results: Oleoyl-CoA regulates binding of the RaaS transcription factor to DNA and thus expression of the RaaS regulon and
RaaS-mediated persistence.
Conclusion: The activity of bacterial efflux is regulated by metabolites that are produced during active growth.
Significance: Dysregulation of efflux pumps results in killing of persisting mycobacteria with low metabolic activity.
We have recently shown that RaaS (regulator of antimicrobial-
assisted survival), encoded byRv1219c inMycobacterium tubercu-
losis and by bcg_1279c in Mycobacterium bovis bacillus Calmette-
Guérin, plays an important role in mycobacterial survival in
prolonged stationary phase and during murine infection. Here, we
demonstrate that long chain acyl-CoA derivatives (oleoyl-CoA
and, to lesser extent, palmitoyl-CoA) modulate RaaS binding to
DNA and expression of the downstream genes that encode ATP-
dependent efflux pumps. Moreover, exogenously added oleic acid
influences RaaS-mediated mycobacterial improvement of survival
and expression of the RaaS regulon. Our data suggest that long
chain acyl-CoA derivatives serve as biological indicators of the bac-
terial metabolic state. Dysregulation of efflux pumps can be used to
eliminate non-growing mycobacteria.
Tuberculosis remains a major infectious disease, with 8.6
million new cases estimated in 2012 claiming 1.3 million lives
(1). Moreover, the causative agent of tuberculosis,Mycobacte-
rium tuberculosis, is believed to latently infect one-third of the
world’s population (2). Treatment of tuberculosis requires the
administration of a combination of four drugs (isoniazid, rifam-
pin, ethambutol, and pyrazinamide) for at least 6 months. The
remarkable ability ofM. tuberculosis to survive in the infected
host for years is well documented and involves the activation of
complex regulatory pathways, as well as the production of spe-
cialized enzymes and transcriptional regulators (3, 4).
Wehave recently demonstrated that treatmentofmycobacteria
with antimicrobial agents targeting cell wall biosynthesis (ceru-
lenin, isoniazid, or ethambutol) improvesbacterial survival innon-
permissive growth conditions (5). This phenomenon is mediated
by the transcriptional regulator RaaS (regulator of antimicrobial-
assisted survival), which controls expression of putative ATP-de-
pendent efflux pumps (Bcg_1278c/Bcg_1277 in Mycobacterium
bovis bacillus Calmette-Guérin (BCG)4 and Rv1218c/Rv1217c in
M. tuberculosis).Deletionof raaS fromM. tuberculosisorM. bovis
BCG genomes has no effect on mycobacterial growth in logarith-
mic phase. However, the deletion mutants in both mycobacteria
are impaired in long-term survival at stationary phase. Moreover,
theM. bovisBCGdeletionmutantdisplays a survival defect during
macrophage infection in murine lungs and spleen, whereas the
M. tuberculosis deletion mutant does not persist during macro-
phage infection (5). These results demonstrate that RaaS controls
mycobacterial survival in various models of M. tuberculosis dis-
ease. In the present study, we conducted bioinformatic analyses
and predicted that fatty acid derivatives of CoA are putative
ligandsofRaaS.Weconfirmed this experimentallybydemonstrat-
ing specific binding of oleoyl-CoA to RaaS and the role of oleic
acid, a precursor of oleoyl-CoA, in RaaS-mediated mycobacterial
survival. We propose that fatty acid metabolites produced during
active growth are also involved in controlling expression of genes
encoding mycobacterial efflux pumps.
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EXPERIMENTAL PROCEDURES
Organisms and Media—TheM. bovis BCG Glaxo strain was
grown in Sauton’s liquid medium supplemented with albumin-
dextrose complex as described previously (5). Ethambutol and
oleic acid were added, using a 1-ml syringe fitted with a
25-gauge needle, 30 days after inoculation at final concentra-
tions of 98 and 200 ?M, respectively. An equivalent volume of
sterile water was added to control cultures. Bacterial viability
was assayed by counting colony-forming units on 7H10 agar.
Transcriptional Profiling—Total RNA was isolated from 30
ml of early logarithmic (7 days) or stationary phase (31 days)
M. bovis BCG cultures after a 24-h exposure to 200 ?M oleic
acid using the guanidinium thiocyanate/TRIzol method (6).
DNA contamination was removed with Turbo DNA-free
DNase (Ambion) before cDNA was generated using Super-
Script reverse transcriptase II (Invitrogen) as described previ-
ously (7). Quantitative PCR was performed in a Corbett Rotor-
Gene 6000 real-time thermocycler (Qiagen) by application of
ABsolute qPCR SYBR Green mixture (Thermo Scientific) and
gene-specific primers (see Table 1). Calibration curves were
generated for each gene using genomic DNA (regression value
of?0.95 and efficiency of?2.0). Copy numbers of specific tran-
scripts per 1 ?g of RNA were estimated using the Corbett
Rotor-Gene 6000 software and normalized to 16 S rRNA
expression (7). Relative gene expression in treated samples was
calculated as the ratio of normalized gene copy number after
treatment to normalized gene copy number before treatment
and expressed as -fold change.
Purification of Recombinant RaaS—TheM. tuberculosis raaS
gene was cloned into the NdeI and NheI sites of the pET15-Tev
plasmid to generate a hexahistidine-tagged recombinant pro-
tein (4). Protein expression in Escherichia coli BL21(DE3) was
induced by isopropyl ?-D-thiogalactopyranoside at a final con-
centration of 0.2 mM. Recombinant RaaS was purified using a
HiTrap 1-ml IMACHP column (Amersham Biosciences). Site-
directed mutants of RaaS were generated using a GeneArt
mutagenesis kit (Invitrogen) according to the manufacturer’s
instructions.
Fluorescence Anisotropy—The synthetic oligonucleotides,
containing the imperfect direct repeats (Pr14F and Pr14R in
Table 1), were covalently labeled with ATTO 647N succinimi-
dyl ester dye (Invitrogen). Steady-state fluorescence anisotropy
binding titrations were carried out on a Tecan Safire2 micro-
plate reader using a 635-nm light-emitting diode for excitation
and a monochromator set at 680 nm (bandwidth of 20 nm) for
emission in buffer containing 50mMTris-HCl (pH 8.5) and 150
mM NaCl.
Isothermal Titration Calorimetry (ITC)—RaaS protein and
oleoyl-CoA (Sigma) were diluted in 50 mM Tris-HCl (pH 8.5)
and 150 mM NaCl. RaaS (15 ?M in a 1.4-ml cell) was then
titrated at 25 °C by 5-?l injections of the ligand (250 ?M in the
syringe) using aVP-ITC calorimeter (MicroCal). Raw datawere
normalized and corrected for heats of dilution of the ligand.
Binding stoichiometries, enthalpy values, and equilibrium dis-
sociation constants were determined by fitting the corrected
data to a bimolecular interactionmodel usingOrigin 7 software
(OriginLab).
Small-angle X-ray Scattering Experiments and Data Analysis—
Synchrotron x-ray scattering data were collected on the SWING
beamline of the SOLEIL Synchrotron (Gif-sur-Yvette, France)
using a PCCD-170170 detector at a wavelength of 1.03 Å. The
scatteringpatternsweremeasuredbymerging10–20data record-
ings with 1-s exposure time each for several solute concentrations
at 1 and 3 mg/ml. To check for radiation damage, all successive
exposures were compared, and no changeswere detected. Using a
sample-detector distance of 1.8m, a range ofmomentum transfer
of 0.0065? s? 0.6 Å?1 was covered (s? 4?sin(?)/?, where 2? is
the scattering angle, and ? ? 1.5 Å is the x-ray wavelength). The
data were processed using standard procedures and extrapolated
to infinite dilution using the program PRIMUS (8). The forward
scattering, I(0), and the radius of gyration,Rg,were evaluatedusing
Guinier approximation, assuming that at very small angles (s ?
1.3/Rg), the intensity is represented as I(s)? I(0)exp(?s2Rg2)/3).
EMSA—Annealed Pr14F and Pr14R (Table 1), containing the
RaaS-binding site or the raaS upstream region (174 bp), were
used for EMSAs as described previously (5). Briefly, the reac-
tion buffer (10 ?l) contained 50 mM Tris HCl (pH 8.0), 1 mM
EDTA, 50 mM NaCl, 4% (v/v) glycerol, and 1 g of sheared
salmon sperm DNA per reaction. 32P-Labeled annealed oligo-
nucleotides and purified recombinant RaaS were added to the
reaction at concentrations of 60 and 215 nM, respectively,
except where stated otherwise. Oleoyl-CoA, palmitoyl-CoA,
and dodecyl-CoAwere added to samples as indicated. The sam-
ples were incubated for 10 min at room temperature before
running on a polyacrylamide gel as described above. Following
electrophoresis, gels were fixed in 20% (v/v) methanol and 10%
TABLE 1
Oligonucleotides used in this study















a qRT-PCR, quantitative RT-PCR.
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(v/v) glacial acetic acid for 10min, dried at 65 °C under vacuum,
exposed overnight, and scanned with a Canon 5600F scanner.
Native Gel Electrophoresis—Wild-type RaaS and site-di-
rectedmutantswere loaded onto 10% (w/v) polyacrylamide gels
and run in 0.5?Tris borate/EDTA buffer (pH 8.5) for 20min at
230 V. Gels were stained using colloidal Coomassie Blue stain
(Sigma). Oleoyl-CoA was added at concentrations of 30 and
60 ?M.
RESULTS
Prediction of Putative RaaS Ligands Using Bioinformatic
Approaches—RaaS is annotated as a member of the TetR tran-
scriptional regulator family (pfam00440). It has a short N-ter-
minal DNA-binding domain and a C-terminal domain com-
prising the effector-binding site. The latter is responsible for
the conformational and dynamic changes that regulate DNA
binding. Many TetR proteins control expression of multidrug
efflux pump systems in which DNA binding of the repressor is
regulated by the corresponding exported drug that interacts
with the ligand-binding domain (9). However, we could not
detect direct binding of RaaS to any of the antimicrobials
(ethambutol, isoniazid, and cerulenin) that enhance mycobac-
terial survival (5); the ITC traces displayed identical spikes with
increasing antimicrobial concentrations (up to 5 mM).
A sequence similarity search using PSI-BLAST identified
RaaS as amember of the TetR family (1.4? 10?10) based on the
alignment of the first 60 N-terminal residues only. This search
did not reveal any close homologs that might indicate the
nature of the ligand regulating the RaaS activity. Close
homologs (whose ligands are unknown) are found in mycobac-
teria, with sequence identities ranging from 99% (Mycobacte-
rium marinum; 2 ? 10?118) to 74% (Mycobacterium avium;
9 ? 10?101). More distant homologs are also found in other
actinobacteria, with sequence identities ranging between 56%
(Rhodococcus jostii; 1 ? 10?70) to 48% (Streptomyces sulphu-
reus; 8? 10?52).
Extensive -fold recognition analysis was performed using the
@TOME-2 server (10), and a structural alignment with pro-
teins sharing low sequence identity (?20%) with RaaS was gen-
erated. These distantly related proteins share a strong hydro-
phobic ligand-binding pocket within the C-terminal domain.
One of these proteins, YsiA (FadR), is a transcriptional regula-
tor of the fatty acid degradation pathway in Bacillus subtilis,
and its structure has been solved in complex with stearoyl-CoA
(Protein Data Bank ID 3WHB) (11). Comparative modeling of
RaaS suggested that it has features compatible with the binding
of the CoA moiety of the acyl-CoA ligand, despite a low
sequence identity to the regulator domain of YsiA (14%) (Fig. 1).
In particular, the C-terminal domains (involved in ligand bind-
ing) of both proteins contain conservation clusters around a
short motif DXR (Asp-138 and Arg-140 in RaaS). The con-
served aspartate does not interact directly with the effector, but
instead, it is involved in N-terminal cap of an ?-helix and in the
formation of a salt bridge with the conserved arginine. Arg-140
is then well positioned to directly interact with the adenosine
acyl-CoA moiety of the YsiA ligand (ID 3WHB). We examined
residues in the neighborhood position of the DXR motif. The
Gln-154 lateral chain in FadR points toward the ligand in the
YsiA structure. This residue is Arg-144 in RaaS. The substitu-
tion of glutamine to arginine suggests a possible salt bridgewith
the diphosphate group of acyl-CoA.Arg-144 is conserved in the
close RaaS homologs and in FadR. In addition, for the RaaS
models generated, Arg-144 is compatible with acyl-CoA bind-
ing. Further analysis of the dimeric structure of YsiA high-
lighted the possible role of Tyr-174 (corresponding to Tyr-174
in RaaS). This residue in the monomer is in contact with the
ligand molecule bound to the other monomer. The aromatic
ring of the tyrosine is stacked with the adenine ring of the acyl-
CoA ligand. Thus, according to our dimer model, Tyr-174 in
RaaS was postulated to play the same role as Tyr-174 in YsiA to
stabilize the bound acyl-CoA. On the basis of these observa-
FIGURE 1. Sequence alignment of the B. subtilis YsiA protein with the M. tuberculosis RaaS protein (Rv1219c) and its orthologs M. tuberculosis BCG
(Bcg_1279c), M. marinum (WP_020726245), M. avium (WP_019306469), and R. jostii (YP_702919). The alignment was generated using PSI-BLAST and
edited. Conserved residues involved in CoA binding in B. subtilis YsiA are indicated by stars. Protein secondary element assignments, shown above the
sequences, were made only for the N-terminal (DNA-binding) domain due to the low level of sequence identity within the C-terminal domain (14%). The
numbering of amino acids corresponds to theM. tuberculosis (Mtb) RaaS protein. HTH, helix-turn-helix.
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tions, we hypothesized that CoA derivatives of fatty acidsmight
regulate RaaS-DNA binding.
Oleoyl-CoA Regulates RaaS Binding to DNA—Mycobacterial
growth media and eukaryotic cells (a natural niche for myco-
bacterial replication and persistence) are rich sources of oleate
(12). Mycobacteria convert oleate to oleoyl-CoA by fatty acyl-
CoA ligases (13), and oleoyl-CoA is an abundant fatty acid pre-
cursor for the synthesis of mycobacterial cell wall components.
Therefore, we tested the effect of oleoyl-CoA on the RaaS-DNA
interaction using EMSAs. As shown in Fig. 2A, oleoyl-CoA was
able to completely abolish the RaaS-mediated band shift at con-
centrations?15 ?M. Using ITC, we demonstrated direct bind-
ing of oleoyl-CoA to RaaS and a dissociation constant (Kd) for
oleoyl-CoA binding to RaaS of 3.65? 0.28 ?M (Fig. 2B).
We next investigated whether other acyl-coenzyme deriva-
tives have any effect of the RaaS-DNA complex. Lauroyl-CoA
(C12:0), palmitoyl-CoA (C16:0), and palmitoleoyl-CoA (C16:1)
had no effect on the band shift in the EMSA (Fig. 3, A–C).
Stearoyl-CoA (C18:0) showed a dose-dependent inhibition;
however, it did not eliminate RaaS-DNA binding even at the
highest concentration tested, 100 ?M (Fig. 3D). These results
suggest that RaaS preferably binds C18 fatty acid derivatives
(C18:1 oleoyl-CoA or, to some extent, C18:0 stearoyl-CoA). Lon-
ger acyl-CoA metabolites (?C18) could not be tested in our
assay due to their poor solubility.
Role of ConservedAminoAcids inDNAand LigandBinding—
Our thorough sequence structure analysis (see above) sug-
gested that three amino acids could be responsible for acyl-CoA
binding in RaaS: Arg-140, Arg-144, and Tyr-174. Using site-
directed mutagenesis, we generated three RaaS mutants in
which these residues were replaced with alanine: R140A,
R144A, and Y174A.
We first confirmed the structural integrities of the RaaS pro-
teins by performing small-angle x-ray scattering experiments.
FIGURE 2.Oleoyl-CoA regulates RaaSbinding toDNA.A, purified RaaS (215
nM) wasmixed with radiolabeled annealed Pr14F/Pr14R oligonucleotides (60
nM); oleoyl-CoAwas added as indicated. B, characterization of the interaction
between RaaS and oleoyl-CoA by ITC. Samples were prepared as described
under “Experimental Procedures.” Oleoyl-CoA bound to RaaS with a Kd of
3.65? 0.28?M in an enthalpy-driven reaction (?H? ?6.42? 0.14 kcal/mol).
The band shift identifying RaaS binding to DNA is marked with and arrow.






















A Lauroyl CoA (C12:0)
FIGURE 3. Effect of acyl-CoA derivatives on RaaS-DNA binding. Lauroyl-
CoA (A), palmitoyl-CoA (B), palmitoleoyl-CoA (C), stearoyl-CoA (D), and oleoyl-
CoA (E) were added at 0, 5, 10, 25, 50, and 100 ?M, respectively.
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Guinier plot analysis yielded radii of gyration of 30.4? 1, 29.7?
1.8, and 30.7? 1.3 Å for the wild-type and mutant R144A and
Y174A proteins, respectively. The R140A mutant was unstable
at high concentrations, and therefore, it was not possible to
obtain reliable data for this protein. The apparent molecular
masses calculated from the I(0) values were 40, 44, and 40 kDa
for wild-type RaaS, R144A, and Y174A, respectively, confirm-
ing that all proteins were present as folded homodimers in
solution.
We next investigated their binding to DNA. All three muta-
tions caused substantial increases in the dissociation constant
measured by fluorescence anisotropy, ranging from 129 ? 70
nM for R144A to 611 ? 120 and 654 ? 300 nM for Y174A and
R140A, respectively, compared with 31? 6 nM determined for
wild-type RaaS (Fig. 4). The reduced DNA binding affinity
resulting from these mutations was consistent with the results
of EMSAs. As shown in Fig. 5A, the mutant proteins did not
cause substantial DNA band shifts under the conditions used.
The observed changes in the RaaS-DNA binding affinity in the
wild-type and mutant proteins could be explained by altered
RaaS conformation and/or flexibility, as observed in other
TetR-like regulators (14). We therefore could not use EMSA to
investigate the influence of oleoyl-CoA on the interaction of
mutant RaaS with its DNA-binding site. The mutants also
required higher oleoyl-CoA concentrations for titration in ITC
experiments compared with wild-type RaaS. In fact, the RaaS-
oleoyl-CoA binding affinities for themutant proteins could not
be measured by ITC because oleoyl-CoA aggregates at the high
concentrations required (?300 ?M), reducing data quality. We
therefore employed native gel electrophoresis to investigate
oleoyl-CoA binding to RaaS mutants, measuring the effect of
oleoyl-CoA binding onmigration of RaaS proteins. As shown in
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FIGURE 4.Mutations in the predicted ligand-binding domain influence RaaS-DNA binding as measured by fluorescence anisotropy. Shown are the
anisotropy affinity profiles for the interactions of ATTO 647N-DNA (4 nM) with wild-type RaaS (A), R144A (B), Y174A (C), and R140A (D).
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B
FIGURE 5. Site-directed mutations alter RaaS interaction with DNA and
ligand binding. A, the mutant proteins were used for EMSA. Radiolabeled
32P-labeled annealed Pr14 oligonucleotides (200 nM) were mixed with puri-
fied RaaS at two concentrations (0.7 and 3.5 ?M). B, native electrophoresis of
wild-type RaaS andmutants R140A, R144A, and Y174A. RaaS and its mutants
(200 nM) were loaded onto a 10% (w/v) polyacrylamide gel. Arrows indicate a
shifted protein band corresponding to the complex between RaaS and
oleoyl-CoA.
Oleoyl-CoA Is a Ligand of RaaS
SEPTEMBER 5, 2014•VOLUME 289 •NUMBER 36 JOURNAL OF BIOLOGICAL CHEMISTRY 25245
rapidmigration of RaaS and an apparent reduction in size (indi-
cated with an arrow), which could be explained either by disso-
ciation of the dimer to a monomeric form or by an altered
protein charge or flexibility. Treatment of the mutant proteins
with 30 ?M oleoyl-CoA had no pronounced effect on their
migration patterns, whereas the addition of 60 ?M oleoyl-CoA
had a partial effect, resulting in formation of two forms of RaaS
(Fig. 5B). These results suggest that the conserved amino acids
in the ligand-binding domain are indeed involved in binding
oleoyl-CoA.
Oleic Acid Influences RaaS-mediated Biological Effects—
Finally, to confirm the biological relevance of our findings with
oleoyl-CoA, we investigated the effect of oleic acid on expres-
sion of the RaaS regulon and the drug-mediated improvement
ofM. bovis BCG survival. We have recently shown that RaaS is
an autorepressor protein, and its regulon includes several genes
encoding efflux pumps and conserved proteins of unknown
function (5). In mycobacterial cells, oleic acid is converted to
oleoyl-CoA by the coordinated action of fatty acyl-AMP ligases
and acyl-CoA-synthesizing fatty acyl-CoA ligases (12), result-
ing in an increase in intracellular acyl-CoA concentration. An
increase in oleoyl-CoA concentration should prevent the tran-
scriptional repressor RaaS from binding DNA, leading to ele-
vated expression of the RaaS efflux regulon in nonreplicating
mycobacteria, which is detrimental to long-term survival.
Expression levels of selected genes belonging to the RaaS regu-
lon were measured using quantitative RT-PCR. We compared
the effect of oleic acid treatment on expression of raaS,
bcg_1277c, bcg_1278c, and drrC in logarithmic and stationary
growth phases. Oleic acid had no statistically significant effect
on expression of these genes in logarithmic phase (Fig. 6A).
However, expression of RaaS-regulated genes (bcg_1277c,
bcg_1278c, and drrC) was induced by 4.8-, 2.7-, and 3.7-fold,
respectively, in stationary phase M. bovis BCG cultures 24 h
after treatment with oleic acid (Fig. 6A). Expression of raaS (in
the same operon as bcg_1277c and bcg_1278c) in stationary
phase mycobacteria was also increased after treatment with
oleic acid. Exposure of log phase mycobacteria to oleic acid did
not result in growth alteration (Fig. 5B). Strikingly, the addition
of oleic acid to 1-month-old stationary phase cultures com-
pletely abolished the antimicrobial survival-enhanced effect
(Fig. 6C) mediated by RaaS, thus implicating oleoyl-CoA in the
regulation of long-term mycobacterial survival.
DISCUSSION
Expression of bacterial operons is tightly controlled by tran-
scription factors, repressors or activators, which alter transcript
levels in response to physiological bacterial state or environmental
cues (15). In some cases, as pertinent here for RaaS, repressors are
cotranscribedwith their regulon (14).RaaS is a transcriptional reg-
ulator that plays an important role in long-term mycobacterial
survival in vitro and in vivo (5). Moreover, RaaS mediates an
improvement in mycobacterial survival after exposure of nonrep-
licating bacteria to antimicrobial agents targeting cell wall biosyn-
thesis. Here, we have demonstrated that the RaaS-DNA complex
is regulated by acyl-CoAs, specifically oleoyl-CoA and, to a lesser
extent, stearoyl-CoA (Figs. 2B and 3). The addition of oleic acid, a
precursor of oleoyl-CoA, completely abolished the survival-pro-
moting effects of ethambutol and dysregulated the RaaS regulon
(Fig. 5), confirming the biological relevance of oleoyl-CoA as a
regulator of mycobacterial persistence.
During the preparation of thismanuscript, a crystal structure
of RaaS (Rv1219c) was solved (16). The structure analysis con-
firmed our predictions concerning the importance of Arg-140
and Arg-144, but not Tyr-174, in ligand binding. However, the
structure revealed the presence of a very large hydrophobic
cavity of 880 Å compared with the calculated volume of the
aliphatic chain of oleoyl-CoAof 345Å (Fig. 7B). TheRaaS cavity
size significantly exceeds volumes of the binding pocket of YsiA
(403Å) (Fig. 7A) or othermycobacterial TetR regulators such as
EthR (399 Å; Protein Data Bank ID 4DW6) and KstR (190 Å; ID
3MNL). This striking difference in the RaaS structure indicates
that other longer chain acyl-CoAs or complex lipids containing


























































FIGURE 6. Oleic acid influences RaaS-mediated biological phenomena. A,
effect of oleic acid on expression of genes from the RaaS regulon. Shown is the
relative expression of selected genes from the RaaS regulon in stationary phase
cultures treatedwith oleic acid. The genes were statistically significantly overex-
pressed in oleate-treated stationary cultures compared with water-treated con-
trols (t test, p ? 0.01). B, effect of oleic acid on the growth of M. bovis BCG at
logarithmic phase. Oleic acid (OA; 200?M)was added before inoculation of bac-
teria (E) or to a growing mycobacterial culture with A580 nm ? 0.2, indicated by
the arrow (‚). C, oleic acid eliminates the RaaS-mediated improvement of
M. bovis BCG survival. Oleic acid abolished the protective effect of ethambutol
treatmentundernonpermissivegrowth conditions. Emb, ethambutol. ***, statis-
tically different from the water control and ethambutol ? oleic acid (t test, p ?
0.001).
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regulate the DNA-binding activity of RaaS. Mycobacteria are
able to produce and export a great variety of lipids containing
fatty acids from oleic acid itself (17) to acyl-trehaloses (18). It is
possible that the RaaS-regulated Rv1218c/Rv1217c pump is
involved in the export of these oleate-containing lipids. More-
over, DrrC (which may also be regulated by RaaS) has been
implicated in the export of the complex lipid phthiocerol dimy-
cocerosate inM. tuberculosis (19).
Derivatives of fatty acids have been previously demonstrated
to regulate the expression of mycobacterial lipid transporters
(20). Our findings support the importance of acyl-CoA metab-
olites in the regulation of mycobacterial efflux and long-term
persistence. As free acyl-CoA accumulates, RaaS is released
from its DNA-binding site, and downstream genes encoding
efflux pumps are expressed (Fig. 8A). Depletion of free acyl-
CoA allows RaaS to bind to DNA, resulting in repression of the
downstream transporter genes (Fig. 8B).
ATP-dependent efflux pumps are integral components of
the energy and metabolic circuitry of growing cells, and their
activity depends on the metabolic state of bacteria, which
may be finely tuned by metabolites binding to transcrip-
tional regulators. In non-growing cells, the levels of acyl-
CoAs drop following the slowing down of metabolism.
Under stressful conditions (for example, hypoxia or iron
limitation), mycobacteria can redirect carbon flux from the
tricarboxylic acid cycle to alternative metabolic pathways
and to the synthesis of triacylglycerols (21, 22). This mech-
anism is important for long-term survival, as it generates
storage compounds, removes toxic fatty acid derivatives, and
depletes free fatty acids and their CoA derivatives (21, 22).
We hypothesize that under stressful conditions or to survive
long-term during infection, free RaaS binds to its DNA recog-
nition sequence, repressing the transcription of this cluster of
efflux pump genes and itself in a classical feedback loop (Fig. 8).
FIGURE 7.Volumeof hydrophobic cavities in RaaSandYsiA. Shownare the crystal structures of YsiA in red (ProteinData Bank ID 3WHB) (A) and RaaS in green
(ID 4NN1) (B). The two proteins display hydrophobic cavities of different volumes: 403 Å for YsiA (shown in blue in A) and 880 Å for RaaS (shown in red in B). The
volumes were calculated with POCASA 1.0, and the figure was generated using PyMOL and HOLLOW (27).
FIGURE 8. Schematic representation of proposed RaaS function. A, in growing cells, RaaS is bound by acyl-CoA, and the Rv1218c/Rv1217c-encoded
ATP-dependent pump is expressed. B, antimicrobial treatment of stationary phaseM. bovis BCG cells results in inhibition of residual cell wall biosynthesis and
depletion of acyl-CoA. In the absence of circulating acyl-CoA, RaaS binds to its recognition sequence, preventing expression of the downstream genes
encoding the ATP-binding cassette (ABC) transporter. FAS, fatty acid synthase; FACL, fatty acyl-CoA ligase; TAG, triacylglycerols. Dysregulation of this system
preferentially impairs slow/non-growing bacilli.
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We further propose that antimicrobial treatment potentiates
this process, directly or indirectly inhibiting fatty acid synthases
and rapidly depleting residual (C16–C18 chain) fatty acid pre-
cursors (23–25).
We have shown that RaaS is a component of the complex
regulatory mechanisms orchestrating a coordinated down-reg-
ulation of energy-consuming processes and the activation of
long-term persistence. This is supported by our previous find-
ings that M. tuberculosis employs the RaaS-mediated mecha-
nism for in vitro persistence in prolonged stationary phase and
during in vivo macrophage and mouse infections (5). Trans-
poson inactivation of Rv1218c results in the highest fitness cost
inmacrophage culture (26), but the precise physiological role of
the Rv1218c/Rv1217c (Bcg_1278c/Bcg_1277c) pump remains
unknown.We propose that Rv1218c/Rv1217c likely transports
lipid molecule(s) that are important for the initial stages of
infection andmay become toxic or are dispensable during non-
replicating persistence. Our findings suggest that this putative
lipid contains fatty acid moieties (oleic and possibly also stearic
acids), which are highly abundant in growing mycobacteria (as
CoA derivatives) and are rapidly depleted in nonpermissive
growth conditions. Our sequence analysis extended to Rv1216c
and Rv1215c (Bcg_1276c and Bcg_1275c) highlights distant
similarities to an S-adenosylmethionine-dependent mem-
brane-embedded methyltransferase and a lipid esterase/trans-
ferase. Accordingly, these proteins might be predicted to mod-
ify a lipid precursor to be secreted by the Rv1218c/Rv1217c
(Bcg_1278c/Bcg_1277c) efflux pump. Future experiments will
focus on the nature of the molecules transported by Rv1218c/
Rv1217c (Bcg_1278c/Bcg_1277c) and elucidation of their pre-
cise roles in mycobacterial growth, infection, and persistence.
Our findings indicate that dysregulation of efflux pumps can be
employed to kill non-growing mycobacteria.
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